Mikael Segerlantz

knuten till universitetet, Överläkare, MD, Ph.D
Fler filtreringsmöjligheter
  1. 2020
  2. 2019
  3. Low-Dose Oral Ketamine for Procedural Analgesia in Pediatric Cancer Patients Undergoing Lumbar Puncture at a Resource-Limited Cancer Hospital in India

    Rayala, S., Bäckdahl, T., Reddy, N., Jacob, J., Gebre-Medhin, E., Karonen, E., Palat, G., Sinha, S., Schyman, T., Thomas Wiebe, Eva Brun & Mikael Segerlantz, 2019 okt 25, I : Journal of Palliative Medicine. 22, 11, s. 1357-1363

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Procedural pain in lumbar punctures and the impact of preparation in pediatric cancer patients

    Sinha, S., Marczak, M., Jacob, J., Palat, G., Eva Brun, Thomas Wiebe, Schyman, T. & Mikael Segerlantz, 2019 apr 1, I : Indian Journal of Medical and Paediatric Oncology. 40, 2, s. 182-192

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Palliative sedation via intraosseous vascular access: A safe and feasible way to obtain a vascular access end of life

    Mansfeld, A., Radafshar, M., Thorgeirsson, H., Hoïjer, C. J. & Mikael Segerlantz, 2019 jan 11, I : Journal of Palliative Medicine. 22, 1, s. 109-111

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Low-dose oral ketamine as a procedural analgesia in pediatric cancer patients undergoing bone marrow aspirations at a resource-limited cancer hospital in India

    Rayala, S., Kyander, M., Haridass, V., Palat, G., Ström, A., Thomas Wiebe, Eva Brun & Mikael Segerlantz, 2019, I : Indian Journal of Palliative Care. 25, 4, s. 501-507 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Treatment adherence and abandonment in acute myeloid leukemia in pediatric patients at a low-resource cancer center in India

    Sinha, S., Brattström, G., Palat, G., Rapelli, V., Mikael Segerlantz, Eva Brun & Thomas Wiebe, 2019, I : Indian Journal of Medical and Paediatric Oncology. 40, 4, s. 501-506 6 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. 2018
  9. Cancer Treatment and End-of-Life Care

    Sinha, S., Matharu, J. K., Jacob, J., Palat, G., Eva Brun, Thomas Wiebe & Mikael Segerlantz, 2018 aug, I : Journal of Palliative Medicine. 21, 8, s. 1100-1106

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. End-of-life treatments in pediatric patients at a government tertiary cancer center in India

    Jacob, J., Matharu, J. K., Palat, G., Sinha, S., Eva Brun, Thomas Wiebe & Mikael Segerlantz, 2018 jul 1, I : Journal of Palliative Medicine. 21, 7, s. 907-912

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Specialized palliative care and the quality of life for hospitalized cancer patients at a low-resource hospital in India

    Palat, G., Stenlander, C., Jacob, J., Sinha, S., Rapelli, V., Thomas Wiebe, Eva Brun & Mikael Segerlantz, 2018 jul 1, I : Indian Journal of Palliative Care. 24, 3, s. 289-299 11 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. 2005
  13. Insulin sensitivity in adults with growth hormone deficiency and effect of growth hormone treatment.

    Leif Groop, Mikael Segerlantz & Bramnert, M., 2005, I : Hormone Research. 64 , Suppl 3, s. 45-50

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. 2004
  15. Effects of morning cortisol replacement on glucose and lipid metabolism in GH-treated subjects.

    Mikael Segerlantz, Bramnert, M., Ronnie Thomasson, Manhem, P., Esa Laurila & Leif Groop, 2004, I : European Journal of Endocrinology. 151, 6, s. 701-707

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Metabolic Effects of Growth Hormone Replacement Therapy in Adults - with Special Reference to Insulin Sensitivity

    Mikael Segerlantz, 2004, Dr. Mikael Segerlantz, Östervångsvägen 15, 224 60 Lund, Sweden,. 65 s.

    Forskningsoutput: AvhandlingDoktorsavhandling (sammanläggning)

  17. 2003
  18. Growth hormone replacement therapy induces insulin resistance by activating the glucose-Fatty Acid cycle.

    Bramnert, M., Mikael Segerlantz, Esa Laurila, Daugaard, J. R., Manhem, P. & Leif Groop, 2003, I : Journal of Clinical Endocrinology and Metabolism. 88, 4, s. 1455-1463

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. 2001
  20. Inhibition of the rise in FFA by Acipimox partially prevents GH-induced insulin resistance in GH-deficient adults

    Mikael Segerlantz, Bramnert, M., Manhem, P., Esa Laurila & Leif Groop, 2001, I : Journal of Clinical Endocrinology and Metabolism. 86, 12, s. 5813-5818

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift